Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Durvalumab

NCT05303532 · clinicaltrials.gov ↗

PHASE3

Phase

ENROLLING_BY_INVITATION

Status

214

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer

Interventions

DRUG: Durvalumab

Sponsor

AstraZeneca